JPWO2019152627A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019152627A5 JPWO2019152627A5 JP2020541528A JP2020541528A JPWO2019152627A5 JP WO2019152627 A5 JPWO2019152627 A5 JP WO2019152627A5 JP 2020541528 A JP2020541528 A JP 2020541528A JP 2020541528 A JP2020541528 A JP 2020541528A JP WO2019152627 A5 JPWO2019152627 A5 JP WO2019152627A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- subject
- composition according
- dapansutrile
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862624637P | 2018-01-31 | 2018-01-31 | |
| US62/624,637 | 2018-01-31 | ||
| PCT/US2019/016012 WO2019152627A1 (en) | 2018-01-31 | 2019-01-31 | Method for preventing or treating alzheimer's disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021512086A JP2021512086A (ja) | 2021-05-13 |
| JPWO2019152627A5 true JPWO2019152627A5 (de) | 2022-01-31 |
| JP7290872B2 JP7290872B2 (ja) | 2023-06-14 |
Family
ID=67478566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020541528A Active JP7290872B2 (ja) | 2018-01-31 | 2019-01-31 | アルツハイマー病の予防又は治療方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11517554B2 (de) |
| EP (1) | EP3746057B1 (de) |
| JP (1) | JP7290872B2 (de) |
| CN (1) | CN111670032A (de) |
| CA (1) | CA3087865A1 (de) |
| MX (1) | MX2020007941A (de) |
| WO (1) | WO2019152627A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7229565B2 (ja) * | 2018-03-21 | 2023-02-28 | オラテック セラピューティクス リミティド ライアビリティ カンパニー | メラノーマを治療するための方法 |
| CN114555053A (zh) * | 2019-10-14 | 2022-05-27 | 欧拉泰克治疗有限责任公司 | 治疗乳腺癌的方法 |
| EP4387729A1 (de) * | 2021-08-19 | 2024-06-26 | Olatec Therapeutics, Inc. | Verfahren zur behandlung von morbus parkinson |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2651407B1 (de) * | 2010-12-15 | 2016-12-21 | Olatec Industries LLC | 3-methansulfonylpropionitril zur behandlung von entzündungen und schmerzen |
| CN109846862A (zh) * | 2012-10-25 | 2019-06-07 | 通用医疗公司 | 治疗阿尔茨海默病及相关疾病的组合疗法 |
| EP3003356B1 (de) * | 2013-05-31 | 2019-07-03 | Regeneron Pharmaceuticals, Inc. | Il-1-antagonisten zur verwendung in der behandlung von morbus alzheimer |
| WO2015165961A1 (en) * | 2014-04-29 | 2015-11-05 | Affiris Ag | Treatment and prevention of alzheimer's disease (ad) |
| AU2016225037B2 (en) * | 2015-02-26 | 2021-06-17 | University Of Kentucky Research Foundation | Compositions and methods for treating retinal degradation |
-
2019
- 2019-01-31 CN CN201980011347.7A patent/CN111670032A/zh active Pending
- 2019-01-31 WO PCT/US2019/016012 patent/WO2019152627A1/en unknown
- 2019-01-31 JP JP2020541528A patent/JP7290872B2/ja active Active
- 2019-01-31 EP EP19746676.6A patent/EP3746057B1/de active Active
- 2019-01-31 MX MX2020007941A patent/MX2020007941A/es unknown
- 2019-01-31 CA CA3087865A patent/CA3087865A1/en active Pending
-
2020
- 2020-07-29 US US16/942,312 patent/US11517554B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2009227629B2 (en) | Dosing regimen for a selective S1P1 receptor agonist | |
| ES2372421T3 (es) | Uso de flibanserina para el tratamiento de trastornos del deseo sexual premenopáusicos. | |
| TWI250016B (en) | Use of pramipexole for the treatment of addictive disorders | |
| JPS6143112A (ja) | 精神性欲機能障害治療剤 | |
| JP2000511873A (ja) | 睡眠時呼吸障害を治療および診断する方法、並びにこの方法を実施する手段 | |
| BR112020008128A2 (pt) | comprimidos de liberação retardada de deferiprona e métodos para utilização dos mesmos | |
| JP2021502392A5 (de) | ||
| MX2024006271A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JPH0761923A (ja) | アルツハイマー病治療剤 | |
| JPWO2019152627A5 (de) | ||
| EP1944030B1 (de) | Wirkstoff zur Behandlung von Schizophrenie | |
| JPH09500121A (ja) | 痴呆症の治療のためのナブメトンまたは６−メトキシナフチル酢酸の使用 | |
| DE60125062T2 (de) | Quetiapin zur Behandlung der Dyskinesie in nicht-psychotischen Patienten | |
| RU2002129298A (ru) | Применение галантамина для лечения психоневрологического поведения, связанного с болезнью альцгеймера | |
| JPWO2021211489A5 (de) | ||
| CN1853619A (zh) | 阿戈美拉汀在获得用于治疗双相性精神障碍的药物中的用途 | |
| JP6420923B1 (ja) | 医薬 | |
| JP2009501205A (ja) | 精神病治療用組成物 | |
| JPH07507280A (ja) | （−）−メトリフォネート含有薬剤 | |
| WO2023066330A1 (zh) | 依达拉奉在自闭症谱系障碍治疗中的应用 | |
| CN106822158B (zh) | 红景天苷用于防治阻塞性睡眠呼吸暂停诱导型高血压 | |
| WO2022241724A1 (zh) | TGFβ通路抑制剂在制备预防或治疗血脑屏障损害的药物或保健品中的应用 | |
| DE69808607T2 (de) | Verfahren zur verwendung von cyclooxygenase-2 hemmern zur behandlung und vorbeugung der demenz | |
| CN114984034A (zh) | 一种寡糖类化合物的应用 | |
| TWI782261B (zh) | 皮質類固醇用於製備治療川崎症引發血管炎的藥物的用途 |